Antibiotic ivermectin selectively induces apoptosis in chronic myeloid leukemia through inducing mitochondrial dysfunction and oxidative stress (2018)

Peer-Reviewed Study · Wang J; Xu Y; Wan H; Hu J · February 2018

Wang J et al., 2018-02: CML study reporting that ivermectin induces caspase-dependent apoptosis more effectively in K562 cells and primary CML CD34+ cells than in normal bone marrow CD34+ cells, through mitochondrial dysfunction and oxidative stress.

In line with this concept, we show that an anthelminthic drug ivermectin selectively kills chronic myeloid leukemia (CML) cells via inducing mitochondrial dysfunctions and oxidative stress.

n/a (PubMed abstract)

Wang J et al., 2018-02: CML study reporting that ivermectin induces caspase-dependent apoptosis more effectively in K562 cells and primary CML CD34+ cells than in normal bone marrow CD34+ cells, through mitochondrial dysfunction and oxidative stress. Study type: CML cell line K562 + primary CML and normal bone marrow CD34+ cells. N: not stated in the abstract. Country: China (Jingzhou Central Hospital). Dose: not stated in the abstract. Funder/COI: not stated in the PubMed record. Comparator: normal bone marrow CD34+ cells.